<<<<<<< HEAD
"","GO.IDs","over_represented_pvalue","under_represented_pvalue","numDEInCat","numInCat","term","ontology","GO.Term","GO.Slim.Term","Cat"
"1","GO:0007141",0.0216767224308375,0.998715523037068,2,8,"male meiosis I","BP","male meiosis I","cell cycle and proliferation","P"
"2","GO:0008285",0.0369494190834348,0.985946760623349,8,125,"negative regulation of cell population proliferation","BP","negative regulation of cell proliferation","cell cycle and proliferation","P"
"3","GO:0048144",0.0447423762128722,1,1,1,"fibroblast proliferation","BP","fibroblast proliferation","cell cycle and proliferation","P"
"4","GO:0007528",0.00973746604287724,0.998138549455526,5,43,"neuromuscular junction development","BP","neuromuscular junction development","cell organization and biogenesis","P"
"5","GO:0048681",0.0181617804122001,0.999056172202005,2,7,"negative regulation of axon regeneration","BP","negative regulation of axon regeneration","cell organization and biogenesis","P"
"6","GO:0070207",0.0211016025051941,0.998733519258995,2,9,"protein homotrimerization","BP","protein homotrimerization","cell organization and biogenesis","P"
"7","GO:0010977",0.0258798835153718,0.996454546132944,3,20,"negative regulation of neuron projection development","BP","negative regulation of neuron projection development","cell organization and biogenesis","P"
"8","GO:0016199",0.0286449748736515,0.996030377141835,3,16,"axon midline choice point recognition","BP","axon midline choice point recognition","cell organization and biogenesis","P"
"9","GO:0032286",0.0350367488865553,1,1,1,"central nervous system myelin maintenance","BP","myelin maintenance in the central nervous system","cell organization and biogenesis","P"
"10","GO:0035063",0.0377099218970607,1,1,1,"nuclear speck organization","BP","nuclear speck organization","cell organization and biogenesis","P"
"11","GO:0006906",0.0443413932445964,0.995816497043217,2,12,"vesicle fusion","BP","vesicle fusion","cell organization and biogenesis","P"
"12","GO:0032528",0.048278483339758,1,1,1,"microvillus organization","BP","microvillus organization","cell organization and biogenesis","P"
"13","GO:0006390",0.0484698024211415,1,1,1,"mitochondrial transcription","BP","transcription from mitochondrial promoter","cell organization and biogenesis","P"
"14","GO:0006391",0.0484698024211415,1,1,1,"transcription initiation from mitochondrial promoter","BP","transcription initiation from mitochondrial promoter","cell organization and biogenesis","P"
"15","GO:0002092",0.0494950587530383,0.994984219550232,2,13,"positive regulation of receptor internalization","BP","positive regulation of receptor internalization","cell organization and biogenesis","P"
"16","GO:0046881",0.0233668701824476,1,1,1,"positive regulation of follicle-stimulating hormone secretion","BP","positive regulation of follicle-stimulating hormone secretion","cell-cell signaling","P"
"17","GO:0051463",0.048278483339758,1,1,1,"negative regulation of cortisol secretion","BP","negative regulation of cortisol secretion","cell-cell signaling","P"
"18","GO:0002902",0.0350367488865553,1,1,1,"regulation of B cell apoptotic process","BP","regulation of B cell apoptosis","death","P"
"19","GO:0033032",0.0350367488865553,1,1,1,"regulation of myeloid cell apoptotic process","BP","regulation of myeloid cell apoptosis","death","P"
"20","GO:0060740",0.00262759318588461,0.999973376241847,2,3,"prostate gland epithelium morphogenesis","BP","","developmental processes",""
"21","GO:0042733",0.00325996788192651,0.99953364959477,5,31,"embryonic digit morphogenesis","BP","embryonic digit morphogenesis","developmental processes","P"
"22","GO:0014033",0.00899357623055123,0.999694091125027,2,6,"neural crest cell differentiation","BP","neural crest cell differentiation","developmental processes","P"
"23","GO:0048663",0.0132413444624262,0.999448043038371,2,6,"neuron fate commitment","BP","neuron fate commitment","developmental processes","P"
"24","GO:0016322",0.0135548918725268,0.998586464129932,3,16,"neuron remodeling","BP","neuron remodeling","developmental processes","P"
"25","GO:0001702",0.0136971117082764,0.998553735102322,3,17,"gastrulation with mouth forming second","BP","gastrulation with mouth forming second","developmental processes","P"
"26","GO:0042475",0.0188149967912385,0.99771710358771,3,20,"odontogenesis of dentin-containing tooth","BP","odontogenesis of dentine-containing tooth","developmental processes","P"
"27","GO:0031018",0.0224899657831526,0.998603427549479,2,9,"endocrine pancreas development","BP","endocrine pancreas development","developmental processes","P"
"28","GO:0051797",0.0233668701824476,1,1,1,"regulation of hair follicle development","BP","regulation of hair follicle development","developmental processes","P"
"29","GO:0002051",0.0239205126907167,1,1,1,"osteoblast fate commitment","BP","osteoblast fate commitment","developmental processes","P"
"30","GO:0010719",0.0240459770790506,0.99862181866401,2,6,"negative regulation of epithelial to mesenchymal transition","BP","negative regulation of epithelial to mesenchymal transition","developmental processes","P"
"31","GO:0048754",0.024703560881487,0.998429838232634,2,8,"branching morphogenesis of an epithelial tube","BP","branching morphogenesis of a tube","developmental processes","P"
"32","GO:0060447",0.0262946251664629,1,1,1,"bud outgrowth involved in lung branching","BP","bud outgrowth involved in lung branching","developmental processes","P"
"33","GO:0060739",0.0262946251664629,1,1,1,"mesenchymal-epithelial cell signaling involved in prostate gland development","BP","mesenchymal-epithelial cell signaling involved in prostate gland development","developmental processes","P"
"34","GO:0060173",0.0265918909794387,0.996299964392007,3,21,"limb development","BP","limb development","developmental processes","P"
"35","GO:0030279",0.0269298615614951,0.998157854132556,2,9,"negative regulation of ossification","BP","negative regulation of ossification","developmental processes","P"
"36","GO:0014866",0.0298034969631144,1,1,1,"skeletal myofibril assembly","BP","skeletal myofibril assembly","developmental processes","P"
"37","GO:0040024",0.0375958563420485,1,1,1,"dauer larval development","BP","dauer larval development","developmental processes","P"
"38","GO:0050771",0.038560111939822,0.996727965197509,2,10,"negative regulation of axonogenesis","BP","negative regulation of axonogenesis","developmental processes","P"
"39","GO:0009792",0.0389134584690063,0.996681460723323,2,10,"embryo development ending in birth or egg hatching","BP","embryonic development ending in birth or egg hatching","developmental processes","P"
"40","GO:0030326",0.0401184695530051,0.993325094705004,3,26,"embryonic limb morphogenesis","BP","embryonic limb morphogenesis","developmental processes","P"
"41","GO:0007370",0.0414130305902067,1,1,1,"ventral furrow formation","BP","ventral furrow formation","developmental processes","P"
"42","GO:0007491",0.0461938788641404,0.999455104933363,1,2,"sternite morphogenesis","BP","sternite morphogenesis","developmental processes","P"
"43","GO:0035223",0.0461938788641404,0.999455104933363,1,2,"leg disc pattern formation","BP","leg disc pattern formation","developmental processes","P"
"44","GO:0035293",0.0461938788641404,0.999455104933363,1,2,"chitin-based larval cuticle pattern formation","BP","chitin-based larval cuticle pattern formation","developmental processes","P"
"45","GO:0042338",0.0469871768802868,1,1,1,"cuticle development involved in collagen and cuticulin-based cuticle molting cycle","BP","collagen and cuticulin-based cuticle development during molting","developmental processes","P"
"46","GO:0060444",0.047501118073766,0.995405875065674,2,11,"branching involved in mammary gland duct morphogenesis","BP","branching involved in mammary gland duct morphogenesis","developmental processes","P"
"47","GO:0045740",0.0386232440920026,0.996665844160128,2,11,"positive regulation of DNA replication","BP","positive regulation of DNA replication","DNA metabolism","P"
"48","GO:0007276",0.000164841260890941,0.999998532143104,3,4,"gamete generation","BP","gamete generation","other biological processes","P"
"49","GO:0030534",0.0069679691288566,0.999103125460547,4,23,"adult behavior","BP","adult behavior","other biological processes","P"
"50","GO:0007611",0.00863377731616836,0.99880619367147,4,25,"learning or memory","BP","learning or memory","other biological processes","P"
"51","GO:0060179",0.014986119777611,0.999296765660677,2,7,"male mating behavior","BP","male mating behavior","other biological processes","P"
"52","GO:0042711",0.0154445867738142,0.999301515306421,2,6,"maternal behavior","BP","maternal behavior","other biological processes","P"
"53","GO:0010225",0.0177781911332594,0.99905222841765,2,8,"response to UV-C","BP","response to UV-C","other biological processes","P"
"54","GO:0032909",0.0233668701824476,1,1,1,"regulation of transforming growth factor beta2 production","BP","regulation of transforming growth factor-beta2 production","other biological processes","P"
"55","GO:0045446",0.0233668701824476,1,1,1,"endothelial cell differentiation","BP","endothelial cell differentiation","other biological processes","P"
"56","GO:0048859",0.0233668701824476,1,1,1,"formation of anatomical boundary","BP","formation of anatomical boundary","other biological processes","P"
"57","GO:0007599",0.0233668701824477,1,1,1,"hemostasis","BP","hemostasis","other biological processes","P"
"58","GO:0000747",0.0233967491261297,1,1,1,"conjugation with cellular fusion","BP","conjugation with cellular fusion","other biological processes","P"
"59","GO:0002724",0.0234923152349697,1,1,1,"regulation of T cell cytokine production","BP","regulation of T cell cytokine production","other biological processes","P"
"60","GO:0014812",0.0238256361451823,1,1,1,"muscle cell migration","BP","muscle cell migration","other biological processes","P"
"61","GO:0010614",0.0306050394204858,0.997709738722449,2,10,"negative regulation of cardiac muscle hypertrophy","BP","negative regulation of cardiac muscle hypertrophy","other biological processes","P"
"62","GO:0043085",0.031547603445136,0.997600107617385,2,10,"positive regulation of catalytic activity","BP","positive regulation of catalytic activity","other biological processes","P"
"63","GO:0030317",0.0327407381728743,0.995019817704602,3,23,"flagellated sperm motility","BP","sperm motility","other biological processes","P"
"64","GO:0060325",0.0334974196997304,0.99742121896662,2,9,"face morphogenesis","BP","face morphogenesis","other biological processes","P"
"65","GO:0032535",0.0350367488865553,1,1,1,"regulation of cellular component size","BP","regulation of cellular component size","other biological processes","P"
"66","GO:0051548",0.0350367488865553,1,1,1,"negative regulation of keratinocyte migration","BP","negative regulation of keratinocyte migration","other biological processes","P"
"67","GO:0035176",0.0412353241112397,0.993086040482319,3,25,"social behavior","BP","social behavior","other biological processes","P"
"68","GO:0048873",0.0425570976271912,0.996125797121594,2,11,"homeostasis of number of cells within a tissue","BP","homeostasis of number of cells within a tissue","other biological processes","P"
"69","GO:0060718",0.0446656696305152,1,1,1,"chorionic trophoblast cell differentiation","BP","chorionic trophoblast cell differentiation","other biological processes","P"
"70","GO:0032675",0.0467644264398172,0.999441396151014,1,2,"regulation of interleukin-6 production","BP","regulation of interleukin-6 production","other biological processes","P"
"71","GO:0032504",0.0495706868537948,0.999371426079658,1,2,"multicellular organism reproduction","BP","multicellular organism reproduction","other biological processes","P"
"72","GO:0016051",0.00462455480130077,0.999681679948201,3,14,"carbohydrate biosynthetic process","BP","carbohydrate biosynthetic process","other metabolic processes","P"
"73","GO:0050651",0.0233668701824477,1,1,1,"dermatan sulfate proteoglycan biosynthetic process","BP","dermatan sulfate proteoglycan biosynthetic process","other metabolic processes","P"
"74","GO:0009710",0.0233671002829646,1,1,1,"tropane alkaloid biosynthetic process","BP","tropane alkaloid biosynthetic process","other metabolic processes","P"
"75","GO:0009247",0.0348546328741351,0.997116861968794,2,12,"glycolipid biosynthetic process","BP","glycolipid biosynthetic process","other metabolic processes","P"
"76","GO:0042983",0.0422406432477342,1,1,1,"amyloid precursor protein biosynthetic process","BP","amyloid precursor protein biosynthetic process","other metabolic processes","P"
"77","GO:0050655",0.0462139676744473,0.999454625213358,1,2,"dermatan sulfate proteoglycan metabolic process","BP","dermatan sulfate proteoglycan metabolic process","other metabolic processes","P"
"78","GO:0006964",0.047635689570834,0.999420125200756,1,2,"positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria","BP","positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria","other metabolic processes","P"
"79","GO:0031397",0.0186456122272938,0.997733639963888,3,21,"negative regulation of protein ubiquitination","BP","negative regulation of protein ubiquitination","protein metabolism","P"
"80","GO:0009249",0.0233668701824477,1,1,1,"protein lipoylation","BP","protein lipoylation","protein metabolism","P"
"81","GO:0018272",0.0293660385793634,1,1,1,"protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine","BP","protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine","protein metabolism","P"
"82","GO:0031293",0.0422406432477342,1,1,1,"membrane protein intracellular domain proteolysis","BP","membrane protein intracellular domain proteolysis","protein metabolism","P"
"83","GO:0042986",0.0422406432477342,1,1,1,"positive regulation of amyloid precursor protein biosynthetic process","BP","positive regulation of amyloid precursor protein biosynthetic process","protein metabolism","P"
"84","GO:0006351",0.0130435809862976,0.997907736808924,4,34,"transcription, DNA-templated","BP","transcription, DNA-dependent","RNA metabolism","P"
"85","GO:0010768",0.0266222847039326,1,1,1,"negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage","BP","negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage","RNA metabolism","P"
"86","GO:0045944",0.0310480569615386,0.983406915028701,18,369,"positive regulation of transcription by RNA polymerase II","BP","positive regulation of transcription from RNA polymerase II promoter","RNA metabolism","P"
"87","GO:0042796",0.0370153442413169,1,1,1,"snRNA transcription by RNA polymerase III","BP","snRNA transcription from RNA polymerase III promoter","RNA metabolism","P"
"88","GO:0070102",0.00128618592472561,1,2,2,"interleukin-6-mediated signaling pathway","BP","interleukin-6-mediated signaling pathway","signal transduction","P"
"89","GO:0060070",0.00163503760607994,0.99980295929832,5,28,"canonical Wnt signaling pathway","BP","Wnt receptor signaling pathway through beta-catenin","signal transduction","P"
"90","GO:0045746",0.00912245916740366,0.999186583897384,3,15,"negative regulation of Notch signaling pathway","BP","negative regulation of Notch signaling pathway","signal transduction","P"
"91","GO:0048013",0.0157211753637245,0.998283926727743,3,15,"ephrin receptor signaling pathway","BP","ephrin receptor signaling pathway","signal transduction","P"
"92","GO:0070495",0.0238256361451823,1,1,1,"negative regulation of thrombin-activated receptor signaling pathway","BP","negative regulation of thrombin receptor signaling pathway","signal transduction","P"
"93","GO:0042921",0.0266222847039326,1,1,1,"glucocorticoid receptor signaling pathway","BP","glucocorticoid receptor signaling pathway","signal transduction","P"
"94","GO:0009789",0.0323433059698716,1,1,1,"positive regulation of abscisic acid-activated signaling pathway","BP","positive regulation of abscisic acid mediated signaling","signal transduction","P"
"95","GO:0048008",0.0423462832517584,0.996293831010713,2,9,"platelet-derived growth factor receptor signaling pathway","BP","platelet-derived growth factor receptor signaling pathway","signal transduction","P"
"96","GO:0060338",0.048278483339758,1,1,1,"regulation of type I interferon-mediated signaling pathway","BP","regulation of type I interferon-mediated signaling pathway","signal transduction","P"
"97","GO:0010286",0.0375958563420485,1,1,1,"heat acclimation","BP","heat acclimation","stress response","P"
"98","GO:0007303",0.00837401794455593,0.999844742126372,2,3,"cytoplasmic transport, nurse cell to oocyte","BP","cytoplasmic transport, nurse cell to oocyte","transport","P"
"99","GO:0060125",0.00840780462071605,0.999780500016559,2,4,"negative regulation of growth hormone secretion","BP","negative regulation of growth hormone secretion","transport","P"
"100","GO:0033686",0.0233668701824476,1,1,1,"positive regulation of luteinizing hormone secretion","BP","positive regulation of luteinizing hormone secretion","transport","P"
"101","GO:0043328",0.0233668701824477,1,1,1,"protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway","BP","protein targeting to vacuole during ubiquitin-dependent protein catabolic process via the MVB pathway","transport","P"
"102","GO:0007589",0.0260812021197803,0.998246408637757,2,9,"body fluid secretion","BP","body fluid secretion","transport","P"
"103","GO:0010766",0.0266222847039326,1,1,1,"negative regulation of sodium ion transport","BP","negative regulation of sodium ion transport","transport","P"
"104","GO:0046824",0.0266222847039326,1,1,1,"positive regulation of nucleocytoplasmic transport","BP","positive regulation of nucleocytoplasmic transport","transport","P"
"105","GO:0043308",0.0479023938487626,0.999413532470105,1,2,"eosinophil degranulation","BP","eosinophil degranulation","transport","P"
"106","GO:0006904",0.0484460746139626,0.995200697964517,2,12,"vesicle docking involved in exocytosis","BP","vesicle docking during exocytosis","transport","P"
"107","GO:0017157",0.0495494485187543,0.994929490782623,2,14,"regulation of exocytosis","BP","regulation of exocytosis","transport","P"
"108","GO:0003198",0.00246140365633011,0.999975885676664,2,3,"epithelial to mesenchymal transition involved in endocardial cushion formation","BP",NA,NA,NA
"109","GO:0060956",0.00246140365633011,0.999975885676664,2,3,"endocardial cell differentiation","BP",NA,NA,NA
"110","GO:0071257",0.00259099044631334,0.999973936242105,2,3,"cellular response to electrical stimulus","BP",NA,NA,NA
"111","GO:0036302",0.00295245395287949,0.999968230244324,2,3,"atrioventricular canal development","BP",NA,NA,NA
"112","GO:2000650",0.00598223831143197,0.999848571170799,2,5,"negative regulation of sodium ion transmembrane transporter activity","BP",NA,NA,NA
"113","GO:0098719",0.00669073839825998,0.999845022734849,2,4,"sodium ion import across plasma membrane","BP",NA,NA,NA
"114","GO:0003344",0.0182522625696351,0.999013244496384,2,8,"pericardium morphogenesis","BP",NA,NA,NA
"115","GO:0003197",0.0206593341366792,0.99880687280685,2,8,"endocardial cushion development","BP",NA,NA,NA
"116","GO:0003220",0.0233668701824476,1,1,1,"left ventricular cardiac muscle tissue morphogenesis","BP",NA,NA,NA
"117","GO:0003251",0.0233668701824476,1,1,1,"positive regulation of cell proliferation involved in heart valve morphogenesis","BP",NA,NA,NA
"118","GO:0061040",0.0233668701824476,1,1,1,"female gonad morphogenesis","BP",NA,NA,NA
"119","GO:1905062",0.0233668701824476,1,1,1,"positive regulation of cardioblast proliferation","BP",NA,NA,NA
"120","GO:1905305",0.0233668701824476,1,1,1,"negative regulation of cardiac myofibril assembly","BP",NA,NA,NA
"121","GO:1905306",0.0233668701824476,1,1,1,"positive regulation of cardiac myofibril assembly","BP",NA,NA,NA
"122","GO:2000617",0.0233668701824476,1,1,1,"positive regulation of histone H3-K9 acetylation","BP",NA,NA,NA
"123","GO:0036090",0.0233668701824477,1,1,1,"cleavage furrow ingression","BP",NA,NA,NA
"124","GO:0097062",0.0234633865790367,1,1,1,"dendritic spine maintenance","BP",NA,NA,NA
"125","GO:0086045",0.0234923152349697,1,1,1,"membrane depolarization during AV node cell action potential","BP",NA,NA,NA
"126","GO:0086047",0.0234923152349697,1,1,1,"membrane depolarization during Purkinje myocyte cell action potential","BP",NA,NA,NA
"127","GO:0086048",0.0234923152349697,1,1,1,"membrane depolarization during bundle of His cell action potential","BP",NA,NA,NA
"128","GO:1903949",0.0234923152349697,1,1,1,"positive regulation of atrial cardiac muscle cell action potential","BP",NA,NA,NA
"129","GO:1904199",0.0234923152349697,1,1,1,"positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization","BP",NA,NA,NA
"130","GO:1904878",0.0237249603047031,1,1,1,"negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel","BP",NA,NA,NA
"131","GO:1903012",0.0237448993464733,1,1,1,"positive regulation of bone development","BP",NA,NA,NA
"132","GO:0071635",0.0238256361451823,1,1,1,"negative regulation of transforming growth factor beta production","BP",NA,NA,NA
"133","GO:1901299",0.0238256361451823,1,1,1,"negative regulation of hydrogen peroxide-mediated programmed cell death","BP",NA,NA,NA
"134","GO:0061344",0.0239205126907167,1,1,1,"regulation of cell adhesion involved in heart morphogenesis","BP",NA,NA,NA
"135","GO:1901189",0.0239205126907167,1,1,1,"positive regulation of ephrin receptor signaling pathway","BP",NA,NA,NA
"136","GO:1990511",0.026248720375388,1,1,1,"piRNA biosynthetic process","BP",NA,NA,NA
"137","GO:0071774",0.0262946251664629,1,1,1,"response to fibroblast growth factor","BP",NA,NA,NA
"138","GO:0071799",0.0262946251664629,1,1,1,"cellular response to prostaglandin D stimulus","BP",NA,NA,NA
"139","GO:0044111",0.0266222847039326,1,1,1,"development involved in symbiotic interaction","BP",NA,NA,NA
"140","GO:1901016",0.0266222847039326,1,1,1,"regulation of potassium ion transmembrane transporter activity","BP",NA,NA,NA
"141","GO:0072560",0.0281895115591259,1,1,1,"type B pancreatic cell maturation","BP",NA,NA,NA
"142","GO:2000078",0.0281895115591259,1,1,1,"positive regulation of type B pancreatic cell development","BP",NA,NA,NA
"143","GO:1902572",0.028787510112485,1,1,1,"negative regulation of serine-type peptidase activity","BP",NA,NA,NA
"144","GO:0086003",0.0292889374285537,1,1,1,"cardiac muscle cell contraction","BP",NA,NA,NA
"145","GO:0086092",0.0292889374285537,1,1,1,"regulation of the force of heart contraction by cardiac conduction","BP",NA,NA,NA
"146","GO:1903281",0.0292889374285537,1,1,1,"positive regulation of calcium:sodium antiporter activity","BP",NA,NA,NA
"147","GO:0044524",0.0293660385793634,1,1,1,"protein sulfhydration","BP",NA,NA,NA
"148","GO:2000290",0.0298034969631144,1,1,1,"regulation of myotome development","BP",NA,NA,NA
"149","GO:1905344",0.0304720081251635,1,1,1,"prostaglandin catabolic process","BP",NA,NA,NA
"150","GO:0071340",0.0314623440106091,0.997610100338096,2,10,"skeletal muscle acetylcholine-gated channel clustering","BP",NA,NA,NA
"151","GO:1900745",0.0323364551390542,0.997506938742361,2,10,"positive regulation of p38MAPK cascade","BP",NA,NA,NA
"152","GO:0036294",0.0350367488865553,1,1,1,"cellular response to decreased oxygen levels","BP",NA,NA,NA
"153","GO:0044320",0.0350367488865553,1,1,1,"cellular response to leptin stimulus","BP",NA,NA,NA
"154","GO:0097107",0.0350367488865553,1,1,1,"postsynaptic density assembly","BP",NA,NA,NA
"155","GO:1903984",0.0350367488865553,1,1,1,"positive regulation of TRAIL-activated apoptotic signaling pathway","BP",NA,NA,NA
"156","GO:2000272",0.0350367488865553,1,1,1,"negative regulation of signaling receptor activity","BP",NA,NA,NA
"157","GO:2000808",0.0350367488865553,1,1,1,"negative regulation of synaptic vesicle clustering","BP",NA,NA,NA
"158","GO:0061065",0.0375958563420485,1,1,1,"regulation of dauer larval development","BP",NA,NA,NA
"159","GO:0061066",0.0375958563420485,1,1,1,"positive regulation of dauer larval development","BP",NA,NA,NA
"160","GO:1901307",0.0397779057523794,1,1,1,"positive regulation of spermidine biosynthetic process","BP",NA,NA,NA
"161","GO:2000348",0.0438647126228865,1,1,1,"regulation of CD40 signaling pathway","BP",NA,NA,NA
"162","GO:1905489",0.0449591916917693,1,1,1,"regulation of sensory neuron axon guidance","BP",NA,NA,NA
"163","GO:1901522",0.0461889632536878,0.999455222285034,1,2,"positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus","BP",NA,NA,NA
"164","GO:0098911",0.0463114834877742,0.999452293468243,1,2,"regulation of ventricular cardiac muscle cell action potential","BP",NA,NA,NA
"165","GO:0072133",0.0463392364974738,0.999451628922234,1,2,"metanephric mesenchyme morphogenesis","BP",NA,NA,NA
"166","GO:0072134",0.0463392364974738,0.999451628922234,1,2,"nephrogenic mesenchyme morphogenesis","BP",NA,NA,NA
"167","GO:0061025",0.0465889790021833,0.999445630271427,1,2,"membrane fusion","BP",NA,NA,NA
"168","GO:1905098",0.0466440110768346,0.999444303943378,1,2,"negative regulation of guanyl-nucleotide exchange factor activity","BP",NA,NA,NA
"169","GO:0072710",0.0469760112274717,0.999436267968782,1,2,"response to hydroxyurea","BP",NA,NA,NA
"170","GO:1900483",0.0479023938487626,0.999413532470105,1,2,"regulation of protein targeting to vacuolar membrane","BP",NA,NA,NA
"171","GO:1903595",0.0479023938487626,0.999413532470105,1,2,"positive regulation of histamine secretion by mast cell","BP",NA,NA,NA
"172","GO:0038127",0.048278483339758,1,1,1,"ERBB signaling pathway","BP",NA,NA,NA
"173","GO:0061582",0.048278483339758,1,1,1,"intestinal epithelial cell migration","BP",NA,NA,NA
"174","GO:0099576",0.0493774636883831,0.999376379536161,1,2,"regulation of protein catabolic process at postsynapse, modulating synaptic transmission","BP",NA,NA,NA
"175","GO:0014701",0.0263797639287717,1,1,1,"junctional sarcoplasmic reticulum membrane","CC","junctional sarcoplasmic reticulum membrane","ER/Golgi","C"
"176","GO:0034098",0.0475963327519759,0.999421094838535,1,2,"VCP-NPL4-UFD1 AAA ATPase complex","CC","Cdc48p-Npl4p-Ufd1p AAA ATPase complex","ER/Golgi","C"
"177","GO:0034245",0.0484698024211415,1,1,1,"mitochondrial DNA-directed RNA polymerase complex","CC","mitochondrial DNA-directed RNA polymerase complex","mitochondrion","C"
"178","GO:0031143",0.0227214871976877,0.998619238277385,2,8,"pseudopodium","CC","pseudopodium","other cellular component","C"
"179","GO:0030314",0.0263797639287717,1,1,1,"junctional membrane complex","CC","junctional membrane complex","other cellular component","C"
"180","GO:0045335",0.0305007118533015,0.995486357059074,3,23,"phagocytic vesicle","CC","phagocytic vesicle","other cellular component","C"
"181","GO:0030686",0.0326673165485236,0.997519204500818,2,9,"90S preribosome","CC","90S preribosome","other cellular component","C"
"182","GO:0042175",0.0245940798972735,1,1,1,"nuclear outer membrane-endoplasmic reticulum membrane network","CC","nuclear envelope-endoplasmic reticulum network","other membranes","C"
"183","GO:0031201",0.0404557776726194,0.996330348139067,2,13,"SNARE complex","CC","SNARE complex","other membranes","C"
"184","GO:0030124",0.0488584831079258,0.999389584626919,1,2,"AP-4 adaptor complex","CC","AP-4 adaptor complex","other membranes","C"
"185","GO:0019897",0.00934267425211216,0.999151159650606,3,16,"extrinsic component of plasma membrane","CC","extrinsic to plasma membrane","plasma membrane","C"
"186","GO:0099524",0.0109405736077751,0.999587593050284,2,6,"postsynaptic cytosol","CC",NA,NA,NA
"187","GO:0036501",0.0234670186700694,1,1,1,"UFD1-NPL4 complex","CC",NA,NA,NA
"188","GO:0098993",0.0245940798972735,1,1,1,"anchored component of synaptic vesicle membrane","CC",NA,NA,NA
"189","GO:0098965",0.028787510112485,1,1,1,"extracellular matrix of synaptic cleft","CC",NA,NA,NA
"190","GO:0090533",0.0292889374285537,1,1,1,"cation-transporting ATPase complex","CC",NA,NA,NA
"191","GO:0035363",0.0370153442413169,1,1,1,"histone locus body","CC",NA,NA,NA
"192","GO:0035577",0.0474272591396462,0.99549031851019,2,10,"azurophil granule membrane","CC",NA,NA,NA
"193","GO:0071547",0.049010480123228,0.999385732176874,1,2,"piP-body","CC",NA,NA,NA
"194","GO:0030297",0.028787510112485,1,1,1,"transmembrane receptor protein tyrosine kinase activator activity","MF","transmembrane receptor protein tyrosine kinase activator activity","enzyme regulator activity","F"
"195","GO:0043027",0.0479526468401703,0.991316931250465,3,32,"cysteine-type endopeptidase inhibitor activity involved in apoptotic process","MF","caspase inhibitor activity","enzyme regulator activity","F"
"196","GO:0004518",0.00112092263303858,0.99987375930978,5,33,"nuclease activity","MF","nuclease activity","other molecular function","F"
"197","GO:0001537",0.00233402207126864,0.999880536438762,3,11,"N-acetylgalactosamine 4-O-sulfotransferase activity","MF","N-acetylgalactosamine 4-O-sulfotransferase activity","other molecular function","F"
"198","GO:0016314",0.00421405953095797,0.999923239803656,2,4,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity","MF","phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity","other molecular function","F"
"199","GO:0010314",0.00674938788517688,0.999818086235761,2,5,"phosphatidylinositol-5-phosphate binding","MF","phosphatidylinositol-5-phosphate binding","other molecular function","F"
"200","GO:0047756",0.0174014933958502,0.999082805918325,2,8,"chondroitin 4-sulfotransferase activity","MF","chondroitin 4-sulfotransferase activity","other molecular function","F"
"201","GO:0050694",0.0226829476777,0.998555143049982,2,10,"galactose 3-O-sulfotransferase activity","MF","galactose 3-O-sulfotransferase activity","other molecular function","F"
"202","GO:0032795",0.0233668701824477,1,1,1,"heterotrimeric G-protein binding","MF","heterotrimeric G-protein binding","other molecular function","F"
"203","GO:0033819",0.0233668701824477,1,1,1,"lipoyl(octanoyl) transferase activity","MF","lipoyl(octanoyl) transferase activity","other molecular function","F"
"204","GO:0050358",0.0233671002829646,1,1,1,"tropinone reductase activity","MF","tropinone reductase activity","other molecular function","F"
"205","GO:0019871",0.0266222847039326,1,1,1,"sodium channel inhibitor activity","MF","sodium channel inhibitor activity","other molecular function","F"
"206","GO:0050815",0.0266222847039326,1,1,1,"phosphoserine residue binding","MF","phosphoserine binding","other molecular function","F"
"207","GO:0045183",0.0269861141419138,1,1,1,"translation factor activity, non-nucleic acid binding","MF","translation factor activity, non-nucleic acid binding","other molecular function","F"
"208","GO:0004123",0.0293660385793634,1,1,1,"cystathionine gamma-lyase activity","MF","cystathionine gamma-lyase activity","other molecular function","F"
"209","GO:0016846",0.0293660385793634,1,1,1,"carbon-sulfur lyase activity","MF","carbon-sulfur lyase activity","other molecular function","F"
"210","GO:0004055",0.0295756148808522,1,1,1,"argininosuccinate synthase activity","MF","argininosuccinate synthase activity","other molecular function","F"
"211","GO:0070273",0.0331544428972097,0.997408979517702,2,10,"phosphatidylinositol-4-phosphate binding","MF","phosphatidylinositol-4-phosphate binding","other molecular function","F"
"212","GO:0051717",0.0350367488865553,1,1,1,"inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity","MF","inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity","other molecular function","F"
"213","GO:0051800",0.0350367488865553,1,1,1,"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity","MF","phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity","other molecular function","F"
"214","GO:0043274",0.038250568282756,0.996768507483421,2,10,"phospholipase binding","MF","phospholipase binding","other molecular function","F"
"215","GO:0001733",0.0382638081016115,0.996633140103562,2,13,"galactosylceramide sulfotransferase activity","MF","galactosylceramide sulfotransferase activity","other molecular function","F"
"216","GO:0005484",0.0391335162885297,0.996514138889945,2,13,"SNAP receptor activity","MF","SNAP receptor activity","other molecular function","F"
"217","GO:0004725",0.044486785282556,0.985304134483713,6,87,"protein tyrosine phosphatase activity","MF","protein tyrosine phosphatase activity","other molecular function","F"
"218","GO:0005502",0.0461889632536878,0.999455222285034,1,2,"11-cis retinal binding","MF","11-cis retinal binding","other molecular function","F"
"219","GO:0004198",0.0476910340791656,0.995377327543585,2,11,"calcium-dependent cysteine-type endopeptidase activity","MF","calcium-dependent cysteine-type endopeptidase activity","other molecular function","F"
"220","GO:0043199",0.0484763700605842,0.999399214620767,1,2,"sulfate binding","MF","sulfate binding","other molecular function","F"
"221","GO:0004991",0.00350142199427077,1,2,2,"parathyroid hormone receptor activity","MF","parathyroid hormone receptor activity","signal transduction activity","F"
"222","GO:0005008",0.0238256361451823,1,1,1,"hepatocyte growth factor-activated receptor activity","MF","hepatocyte growth factor receptor activity","signal transduction activity","F"
"223","GO:0035255",0.0347494397156465,0.997270841626101,2,9,"ionotropic glutamate receptor binding","MF","ionotropic glutamate receptor binding","signal transduction activity","F"
"224","GO:0008020",0.0461889632536878,0.999455222285034,1,2,"G protein-coupled photoreceptor activity","MF","G-protein coupled photoreceptor activity","signal transduction activity","F"
"225","GO:0031748",0.048278483339758,1,1,1,"D1 dopamine receptor binding","MF","D1 dopamine receptor binding","signal transduction activity","F"
"226","GO:0051428",0.048278483339758,1,1,1,"peptide hormone receptor binding","MF","peptide hormone receptor binding","signal transduction activity","F"
"227","GO:0008324",0.023384702484034,1,1,1,"cation transmembrane transporter activity","MF","cation transmembrane transporter activity","transporter activity","F"
"228","GO:0102555",0.0233668701824477,1,1,1,"octanoyl transferase activity (acting on glycine-cleavage complex H protein)","MF",NA,NA,NA
"229","GO:1990782",0.0237379919063544,0.998523193303459,2,8,"protein tyrosine kinase binding","MF",NA,NA,NA
"230","GO:0044540",0.0293660385793634,1,1,1,"L-cystine L-cysteine-lyase (deaminating)","MF",NA,NA,NA
"231","GO:1902051",0.0375958563420485,1,1,1,"(25S)-Delta(4)-dafachronate binding","MF",NA,NA,NA
"232","GO:1902052",0.0375958563420485,1,1,1,"(25S)-Delta(7)-dafachronate binding","MF",NA,NA,NA
"233","GO:0002151",0.0377099218970607,1,1,1,"G-quadruplex RNA binding","MF",NA,NA,NA
"234","GO:0052899",0.0397779057523794,1,1,1,"N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity","MF",NA,NA,NA
"235","GO:0052902",0.0397779057523794,1,1,1,"spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity","MF",NA,NA,NA
"236","GO:0052903",0.0397779057523794,1,1,1,"N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity","MF",NA,NA,NA
"237","GO:0052904",0.0397779057523794,1,1,1,"N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity","MF",NA,NA,NA
"238","GO:0061630",0.0461202878835633,0.982973858252853,7,123,"ubiquitin protein ligase activity","MF",NA,NA,NA
"239","GO:0035516",0.0462283526744958,0.999454281567317,1,2,"oxidative DNA demethylase activity","MF",NA,NA,NA
"240","GO:0019089",0.0493684757718273,0.999376609460611,1,2,NA,NA,"transmission of virus","other biological processes","P"
"241","GO:0030616",0.0233668701824476,1,1,1,NA,NA,"transforming growth factor beta receptor, common-partner cytoplasmic mediator activity","signal transduction activity","F"
=======
"","GO.IDs","over_represented_pvalue","under_represented_pvalue","numDEInCat","numInCat","term","ontology","GO.Term","GO.Slim.Term","Cat","genes","uniprot","uniprot_taxa.id","uniprot.name"
"1","GO:0060070",0.00163484452297326,0.999802987899917,5,28,"canonical Wnt signaling pathway","BP","Wnt receptor signaling pathway through beta-catenin","signal transduction","P","PGEN_.00g208580; PGEN_.00g010610; PGEN_.00g162010; PGEN_.00g299380; PGEN_.00g042660","Q3L254; O75581; Q961D9; C0HL13; O08586","WNT7B_CHICK; LRP6_HUMAN; BCL9_DROME; LRP2_PIG; PTEN_MOUSE","Protein Wnt-7b; Low-density lipoprotein receptor-related protein 6 (LRP-6); Protein BCL9 homolog (Protein legless); Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"2","GO:0042733",0.00325955012583547,0.999533723370006,5,31,"embryonic digit morphogenesis","BP","embryonic digit morphogenesis","developmental processes","P","PGEN_.00g190430; PGEN_.00g325420; PGEN_.00g304170; PGEN_.00g341580; PGEN_.00g290300","O75096; Q6UX40; Q9NSC2; Q13485; P69478","LRP4_HUMAN; TM107_HUMAN; SALL1_HUMAN; SMAD4_HUMAN; CHSTB_RAT","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Transmembrane protein 107; Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1); Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"
"3","GO:0016051",0.00462471046140828,0.999681665376532,3,14,"carbohydrate biosynthetic process","BP","carbohydrate biosynthetic process","other metabolic processes","P","PGEN_.00g049950; PGEN_.00g293980; PGEN_.00g290300","Q8NET6; Q8NCH0; P69478","CHSTD_HUMAN; CHSTE_HUMAN; CHSTB_RAT","Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3); Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1); Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"
"4","GO:0030534",0.00696719324745898,0.999103254092223,4,23,"adult behavior","BP","adult behavior","other biological processes","P","PGEN_.00g211830; PGEN_.00g334800; PGEN_.00g127090; PGEN_.00g042660","P16056; Q9Y4C0; Q92542; O08586","MET_MOUSE; NRX3A_HUMAN; NICA_HUMAN; PTEN_MOUSE","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha); Nicastrin; Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"5","GO:0007611",0.00863288173562053,0.998806353462801,4,25,"learning or memory","BP","learning or memory","other biological processes","P","PGEN_.00g092010; PGEN_.00g279870; PGEN_.00g127090; PGEN_.00g042660","P51816; P00522; Q92542; O08586","AFF2_HUMAN; ABL_DROME; NICA_HUMAN; PTEN_MOUSE","AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein) (FMR2P) (Protein FMR-2) (Protein Ox19); Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson); Nicastrin; Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"6","GO:0014033",0.00899356701281925,0.999694091602565,2,6,"neural crest cell differentiation","BP","neural crest cell differentiation","developmental processes","P","PGEN_.00g010610; PGEN_.00g341580","O75581; Q13485","LRP6_HUMAN; SMAD4_HUMAN","Low-density lipoprotein receptor-related protein 6 (LRP-6); Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)"
"7","GO:0045746",0.00912203036515874,0.999186636188485,3,15,"negative regulation of Notch signaling pathway","BP","negative regulation of Notch signaling pathway","signal transduction","P","PGEN_.00g199570; PGEN_.00g238380; PGEN_.00g258970","Q9VVI3; Q4R562; Q923S6","NEDD4_DROME; ARRB1_MACFA; NEUL1_MOUSE","E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4); Beta-arrestin-1 (Arrestin beta-1); E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1)"
"8","GO:0007528",0.00973660591043179,0.998138754214015,5,43,"neuromuscular junction development","BP","neuromuscular junction development","cell organization and biogenesis","P","PGEN_.00g149640; PGEN_.00g199570; PGEN_.00g327330; PGEN_.00g330670; PGEN_.00g199580","Q80YX1; Q9VVI3; P31696; O60229; P46935","TENA_MOUSE; NEDD4_DROME; AGRIN_CHICK; KALRN_HUMAN; NEDD4_MOUSE","Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C); E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4); Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]; Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain); E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4)"
"9","GO:0006351",0.0130433051063894,0.997907794115661,4,34,"transcription, DNA-templated","BP","transcription, DNA-dependent","RNA metabolism","P","PGEN_.00g207710; PGEN_.00g162010; PGEN_.00g014630; PGEN_.00g009310","Q6NZ06; Q961D9; Q6ZPV2; P48380","ILF2_DANRE; BCL9_DROME; INO80_MOUSE; RFX3_HUMAN","Interleukin enhancer-binding factor 2 homolog; Protein BCL9 homolog (Protein legless); Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80); Transcription factor RFX3 (Regulatory factor X 3)"
"10","GO:0048663",0.0132407801826753,0.999448078990023,2,6,"neuron fate commitment","BP","neuron fate commitment","developmental processes","P","PGEN_.00g341580; PGEN_.00g242340","Q13485; Q01705","SMAD4_HUMAN; NOTC1_MOUSE","Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"11","GO:0016322",0.0135537891795847,0.998586622030422,3,16,"neuron remodeling","BP","neuron remodeling","developmental processes","P","PGEN_.00g215680; PGEN_.00g014370; PGEN_.00g345510","Q24270; Q11002; Q9W0A0","CAC1D_DROME; CANA_DROME; DRPR_DROME","Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D); Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]; Protein draper"
"12","GO:0001702",0.0136962897387184,0.998553854267533,3,17,"gastrulation with mouth forming second","BP","gastrulation with mouth forming second","developmental processes","P","PGEN_.00g010610; PGEN_.00g341580; PGEN_.00g299380","O75581; Q13485; C0HL13","LRP6_HUMAN; SMAD4_HUMAN; LRP2_PIG","Low-density lipoprotein receptor-related protein 6 (LRP-6); Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)"
"13","GO:0060179",0.0149858121886381,0.999296787735701,2,7,"male mating behavior","BP","male mating behavior","other biological processes","P","PGEN_.00g110700; PGEN_.00g042660","G5EFF5; O08586","DAF12_CAEEL; PTEN_MOUSE","Nuclear hormone receptor family member daf-12 (Abnormal dauer formation protein 12); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"14","GO:0042711",0.015443676277473,0.999301578346905,2,6,"maternal behavior","BP","maternal behavior","other biological processes","P","PGEN_.00g330670; PGEN_.00g042660","O60229; O08586","KALRN_HUMAN; PTEN_MOUSE","Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"15","GO:0048013",0.0157199758606422,0.998284106894018,3,15,"ephrin receptor signaling pathway","BP","ephrin receptor signaling pathway","signal transduction","P","PGEN_.00g330670; PGEN_.00g325950; PGEN_.00g127090","O60229; Q06124; Q92542","KALRN_HUMAN; PTN11_HUMAN; NICA_HUMAN","Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain); Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3); Nicastrin"
"16","GO:0010225",0.0177782010160117,0.999052227610788,2,8,"response to UV-C","BP","response to UV-C","other biological processes","P","PGEN_.00g136060; PGEN_.00g060140","Q9C5D2; Q9Y6R4","FBL4_ARATH; M3K4_HUMAN","F-box/LRR-repeat protein 4 (AtFBL4); Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)"
"17","GO:0048681",0.018160516925359,0.999056272837642,2,7,"negative regulation of axon regeneration","BP","negative regulation of axon regeneration","cell organization and biogenesis","P","PGEN_.00g345470; PGEN_.00g042660","F1NWE3; O08586","PTPRS_CHICK; PTEN_MOUSE","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"18","GO:0003344",0.0182519293825894,0.999013272090397,2,8,"pericardium morphogenesis","BP",NA,NA,NA,"PGEN_.00g010610; PGEN_.00g242340","O75581; Q01705","LRP6_HUMAN; NOTC1_MOUSE","Low-density lipoprotein receptor-related protein 6 (LRP-6); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"19","GO:0031397",0.0186452352041301,0.997733703082163,3,21,"negative regulation of protein ubiquitination","BP","negative regulation of protein ubiquitination","protein metabolism","P","PGEN_.00g043790; PGEN_.00g271680; PGEN_.00g061060","P97346; Q5U504; O14514","NXN_MOUSE; KLH40_XENLA; AGRB1_HUMAN","Nucleoredoxin (EC 1.8.1.8) (Protein Red-1); Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5); Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]"
"20","GO:0042475",0.01881413464009,0.997717247706491,3,20,"odontogenesis of dentin-containing tooth","BP","odontogenesis of dentine-containing tooth","developmental processes","P","PGEN_.00g149640; PGEN_.00g190430; PGEN_.00g010610","Q80YX1; O75096; O75581","TENA_MOUSE; LRP4_HUMAN; LRP6_HUMAN","Tenascin (TN) (Hexabrachion) (Tenascin-C) (TN-C); Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Low-density lipoprotein receptor-related protein 6 (LRP-6)"
"21","GO:0003197",0.0206586807412959,0.998806930699577,2,8,"endocardial cushion development","BP",NA,NA,NA,"PGEN_.00g199580; PGEN_.00g242340","P46935; Q01705","NEDD4_MOUSE; NOTC1_MOUSE","E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"22","GO:0070207",0.0211016698784615,0.998733513056504,2,9,"protein homotrimerization","BP","protein homotrimerization","cell organization and biogenesis","P","PGEN_.00g235100; PGEN_.00g341580","Q687X5; Q13485","STEA4_HUMAN; SMAD4_HUMAN","Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9); Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)"
"23","GO:0007141",0.021675753617918,0.998715611164736,2,8,"male meiosis I","BP","male meiosis I","cell cycle and proliferation","P","PGEN_.00g043230; PGEN_.00g008080","Q9D4I2; Q9NQI0","MEII1_MOUSE; DDX4_HUMAN","Meiosis inhibitor protein 1 (Meiosis defective protein 1); Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog)"
"24","GO:0031018",0.0224893405200419,0.998603487153776,2,9,"endocrine pancreas development","BP","endocrine pancreas development","developmental processes","P","PGEN_.00g284780; PGEN_.00g009310","P45448; P48380","NR5A2_MOUSE; RFX3_HUMAN","Nuclear receptor subfamily 5 group A member 2 (Liver receptor homolog 1) (LRH-1); Transcription factor RFX3 (Regulatory factor X 3)"
"25","GO:0010719",0.0240439735267727,0.99862199546029,2,6,"negative regulation of epithelial to mesenchymal transition","BP","negative regulation of epithelial to mesenchymal transition","developmental processes","P","PGEN_.00g051430; PGEN_.00g042660","Q2HJF4; O08586","PBLD_BOVIN; PTEN_MOUSE","Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"26","GO:0048754",0.0247023886384623,0.99842995281009,2,8,"branching morphogenesis of an epithelial tube","BP","branching morphogenesis of a tube","developmental processes","P","PGEN_.00g211830; PGEN_.00g242340","P16056; Q01705","MET_MOUSE; NOTC1_MOUSE","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"27","GO:0010977",0.0258781603110053,0.996454872876845,3,20,"negative regulation of neuron projection development","BP","negative regulation of neuron projection development","cell organization and biogenesis","P","PGEN_.00g327330; PGEN_.00g279870; PGEN_.00g042660","P31696; P00522; O08586","AGRIN_CHICK; ABL_DROME; PTEN_MOUSE","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]; Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"28","GO:0007589",0.026080809691608,0.998246449222913,2,9,"body fluid secretion","BP","body fluid secretion","transport","P","PGEN_.00g164020; PGEN_.00g290440","P16066; Q91V41","ANPRA_HUMAN; RAB14_MOUSE","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A); Ras-related protein Rab-14"
"29","GO:0060173",0.0265898859809897,0.996300350613259,3,21,"limb development","BP","limb development","developmental processes","P","PGEN_.00g190430; PGEN_.00g304170; PGEN_.00g167410","O75096; Q9NSC2; Q9Y2V3","LRP4_HUMAN; SALL1_HUMAN; RX_HUMAN","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1); Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein)"
"30","GO:0030279",0.0269288088033782,0.998157964952874,2,9,"negative regulation of ossification","BP","negative regulation of ossification","developmental processes","P","PGEN_.00g190430; PGEN_.00g242340","O75096; Q01705","LRP4_HUMAN; NOTC1_MOUSE","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"31","GO:0016199",0.0286417734776319,0.996030992826118,3,16,"axon midline choice point recognition","BP","axon midline choice point recognition","cell organization and biogenesis","P","PGEN_.00g199570; PGEN_.00g018080; PGEN_.00g279870","Q9VVI3; G5EFX6; P00522","NEDD4_DROME; SLIT1_CAEEL; ABL_DROME","E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4); Slit homolog 1 protein (Slt-1); Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)"
"32","GO:0010614",0.0306044719484994,0.997709804167106,2,10,"negative regulation of cardiac muscle hypertrophy","BP","negative regulation of cardiac muscle hypertrophy","other biological processes","P","PGEN_.00g341580; PGEN_.00g242340","Q13485; Q01705","SMAD4_HUMAN; NOTC1_MOUSE","Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"33","GO:0045944",0.0310429984461372,0.983409928682999,18,369,"positive regulation of transcription by RNA polymerase II","BP","positive regulation of transcription from RNA polymerase II promoter","RNA metabolism","P","PGEN_.00g211830; PGEN_.00g277910; PGEN_.00g305680; PGEN_.00g010610; PGEN_.00g110700; PGEN_.00g162010; PGEN_.00g284780; PGEN_.00g327330; PGEN_.00g304170; PGEN_.00g341580; PGEN_.00g167410; PGEN_.00g242340; PGEN_.00g299380; PGEN_.00g103430; PGEN_.00g211820; PGEN_.00g014630; PGEN_.00g111970; PGEN_.00g009310","P16056; Q61165; O88873; O75581; G5EFF5; Q961D9; P45448; P31696; Q9NSC2; Q13485; Q9Y2V3; Q01705; C0HL13; Q8WWI1; Q9WUN2; Q6ZPV2; Q8NEZ4; P48380","MET_MOUSE; SL9A1_MOUSE; GMEB2_RAT; LRP6_HUMAN; DAF12_CAEEL; BCL9_DROME; NR5A2_MOUSE; AGRIN_CHICK; SALL1_HUMAN; SMAD4_HUMAN; RX_HUMAN; NOTC1_MOUSE; LRP2_PIG; LMO7_HUMAN; TBK1_MOUSE; INO80_MOUSE; KMT2C_HUMAN; RFX3_HUMAN","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1); Glucocorticoid modulatory element-binding protein 2 (GMEB-2); Low-density lipoprotein receptor-related protein 6 (LRP-6); Nuclear hormone receptor family member daf-12 (Abnormal dauer formation protein 12); Protein BCL9 homolog (Protein legless); Nuclear receptor subfamily 5 group A member 2 (Liver receptor homolog 1) (LRH-1); Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]; Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1); Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin); LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP); Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1); Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80); Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.354) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3); Transcription factor RFX3 (Regulatory factor X 3)"
"34","GO:0071340",0.031461150791629,0.997610240080797,2,10,"skeletal muscle acetylcholine-gated channel clustering","BP",NA,NA,NA,"PGEN_.00g190430; PGEN_.00g327330","O75096; P31696","LRP4_HUMAN; AGRIN_CHICK","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]"
"35","GO:0043085",0.0315468519927862,0.997600195756206,2,10,"positive regulation of catalytic activity","BP","positive regulation of catalytic activity","other biological processes","P","PGEN_.00g032130; PGEN_.00g127090","O94766; Q92542","B3GA3_HUMAN; NICA_HUMAN","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I); Nicastrin"
"36","GO:1900745",0.0323357021633226,0.99750702828512,2,10,"positive regulation of p38MAPK cascade","BP",NA,NA,NA,"PGEN_.00g211830; PGEN_.00g060140","P16056; Q9Y6R4","MET_MOUSE; M3K4_HUMAN","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)"
"37","GO:0030317",0.0327393181674021,0.995020117671309,3,23,"flagellated sperm motility","BP","sperm motility","other biological processes","P","PGEN_.00g211830; PGEN_.00g008080; PGEN_.00g258970","P16056; Q9NQI0; Q923S6","MET_MOUSE; DDX4_HUMAN; NEUL1_MOUSE","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog); E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1)"
"38","GO:0060325",0.0334954158708689,0.997421457154437,2,9,"face morphogenesis","BP","face morphogenesis","other biological processes","P","PGEN_.00g010610; PGEN_.00g325950","O75581; Q06124","LRP6_HUMAN; PTN11_HUMAN","Low-density lipoprotein receptor-related protein 6 (LRP-6); Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)"
"39","GO:0009247",0.0348549776139063,0.99711681796123,2,12,"glycolipid biosynthetic process","BP","glycolipid biosynthetic process","other metabolic processes","P","PGEN_.00g129780; PGEN_.00g237520","P61315; P61315","G3ST3_MOUSE; G3ST3_MOUSE","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3); Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"
"40","GO:0008285",0.0369458860390869,0.985948364568153,8,125,"negative regulation of cell population proliferation","BP","negative regulation of cell proliferation","cell cycle and proliferation","P","PGEN_.00g061060; PGEN_.00g341580; PGEN_.00g228140; PGEN_.00g065870; PGEN_.00g101900; PGEN_.00g242340; PGEN_.00g042660; PGEN_.00g258970","O14514; Q13485; O15164; O75691; P35822; Q01705; O08586; Q923S6","AGRB1_HUMAN; SMAD4_HUMAN; TIF1A_HUMAN; UTP20_HUMAN; PTPRK_MOUSE; NOTC1_MOUSE; PTEN_MOUSE; NEUL1_MOUSE","Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]; Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4); Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24); Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6); Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]; Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog); E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1)"
"41","GO:0050771",0.0385581356839269,0.996728224621268,2,10,"negative regulation of axonogenesis","BP","negative regulation of axonogenesis","developmental processes","P","PGEN_.00g190430; PGEN_.00g042660","O75096; O08586","LRP4_HUMAN; PTEN_MOUSE","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"42","GO:0045740",0.0386225778675204,0.996665933096811,2,11,"positive regulation of DNA replication","BP","positive regulation of DNA replication","DNA metabolism","P","PGEN_.00g211830; PGEN_.00g024960","P16056; Q6BK42","MET_MOUSE; DDI1_DEBHA","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); DNA damage-inducible protein 1 (EC 3.4.23.-)"
"43","GO:0009792",0.0389112609681403,0.996681750679896,2,10,"embryo development ending in birth or egg hatching","BP","embryonic development ending in birth or egg hatching","developmental processes","P","PGEN_.00g015800; PGEN_.00g268850","O76840; Q5U430","PPN1_CAEEL; UBR3_MOUSE","Papilin (Abnormal cell migration protein 6); E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)"
"44","GO:0030326",0.040116059303628,0.993325653458313,3,26,"embryonic limb morphogenesis","BP","embryonic limb morphogenesis","developmental processes","P","PGEN_.00g010610; PGEN_.00g242340; PGEN_.00g290300","O75581; Q01705; P69478","LRP6_HUMAN; NOTC1_MOUSE; CHSTB_RAT","Low-density lipoprotein receptor-related protein 6 (LRP-6); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]; Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"
"45","GO:0035176",0.0412329995050875,0.993086583931719,3,25,"social behavior","BP","social behavior","other biological processes","P","PGEN_.00g334800; PGEN_.00g330670; PGEN_.00g042660","Q9Y4C0; O60229; O08586","NRX3A_HUMAN; KALRN_HUMAN; PTEN_MOUSE","Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha); Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"46","GO:0048008",0.0423428042554372,0.996294303103387,2,9,"platelet-derived growth factor receptor signaling pathway","BP","platelet-derived growth factor receptor signaling pathway","signal transduction","P","PGEN_.00g325950; PGEN_.00g042660","Q06124; O08586","PTN11_HUMAN; PTEN_MOUSE","Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"47","GO:0048873",0.0425556950252008,0.996125994922243,2,11,"homeostasis of number of cells within a tissue","BP","homeostasis of number of cells within a tissue","other biological processes","P","PGEN_.00g325950; PGEN_.00g242340","Q06124; Q01705","PTN11_HUMAN; NOTC1_MOUSE","Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3); Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]"
"48","GO:0006906",0.0443404320163135,0.995816637588999,2,12,"vesicle fusion","BP","vesicle fusion","cell organization and biogenesis","P","PGEN_.00g185010; PGEN_.00g082970","Q8BVI5; Q5ZL74","STX16_MOUSE; VAMP7_CHICK","Syntaxin-16; Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1)"
"49","GO:0060444",0.0474985254458433,0.995406264329211,2,11,"branching involved in mammary gland duct morphogenesis","BP","branching involved in mammary gland duct morphogenesis","developmental processes","P","PGEN_.00g010610; PGEN_.00g299380","O75581; C0HL13","LRP6_HUMAN; LRP2_PIG","Low-density lipoprotein receptor-related protein 6 (LRP-6); Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)"
"50","GO:0006904",0.048443956965075,0.995201023637967,2,12,"vesicle docking involved in exocytosis","BP","vesicle docking during exocytosis","transport","P","PGEN_.00g242750; PGEN_.00g021210","A6H5Z3; Q8K386","EXC6B_MOUSE; RAB15_MOUSE","Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2); Ras-related protein Rab-15"
"51","GO:0002092",0.0494943881559121,0.994984325060638,2,13,"positive regulation of receptor internalization","BP","positive regulation of receptor internalization","cell organization and biogenesis","P","PGEN_.00g199570; PGEN_.00g238380","Q9VVI3; Q4R562","NEDD4_DROME; ARRB1_MACFA","E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4); Beta-arrestin-1 (Arrestin beta-1)"
"52","GO:0017157",0.0495492963654867,0.994929514950535,2,14,"regulation of exocytosis","BP","regulation of exocytosis","transport","P","PGEN_.00g021210; PGEN_.00g228150","Q8K386; A2A825","RAB15_MOUSE; CPLN2_MOUSE","Ras-related protein Rab-15; Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1)"
"53","GO:0019897",0.00934234494708138,0.999151200570106,3,16,"extrinsic component of plasma membrane","CC","extrinsic to plasma membrane","plasma membrane","C","PGEN_.00g165230; PGEN_.00g057380; PGEN_.00g279870","Q8IWY4; Q9ESD1; P00522","SCUB1_HUMAN; PRSS8_MOUSE; ABL_DROME","Signal peptide, CUB and EGF-like domain-containing protein 1; Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]; Tyrosine-protein kinase Abl (EC 2.7.10.2) (D-ash) (Protein abelson)"
"54","GO:0099524",0.0109402804106356,0.999587609911957,2,6,"postsynaptic cytosol","CC",NA,NA,NA,"PGEN_.00g199580; PGEN_.00g042660","P46935; O08586","NEDD4_MOUSE; PTEN_MOUSE","E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"55","GO:0031143",0.0227206311029961,0.998619318189028,2,8,"pseudopodium","CC","pseudopodium","other cellular component","C","PGEN_.00g082970; PGEN_.00g238380","Q5ZL74; Q4R562","VAMP7_CHICK; ARRB1_MACFA","Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1); Beta-arrestin-1 (Arrestin beta-1)"
"56","GO:0045335",0.0304991677938975,0.995486673999712,3,23,"phagocytic vesicle","CC","phagocytic vesicle","other cellular component","C","PGEN_.00g082970; PGEN_.00g290440; PGEN_.00g345510","Q5ZL74; Q91V41; Q9W0A0","VAMP7_CHICK; RAB14_MOUSE; DRPR_DROME","Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1); Ras-related protein Rab-14; Protein draper"
"57","GO:0030686",0.0326658548811509,0.997519375819874,2,9,"90S preribosome","CC","90S preribosome","other cellular component","C","PGEN_.00g270150; PGEN_.00g065870","Q5XGC9; O75691","SRFB1_XENTR; UTP20_HUMAN","Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein); Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)"
"58","GO:0031201",0.0404560786227132,0.996330305916746,2,13,"SNARE complex","CC","SNARE complex","other membranes","C","PGEN_.00g185010; PGEN_.00g082970","Q8BVI5; Q5ZL74","STX16_MOUSE; VAMP7_CHICK","Syntaxin-16; Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1)"
"59","GO:0035577",0.0474239353143848,0.995490809360255,2,10,"azurophil granule membrane","CC",NA,NA,NA,"PGEN_.00g082970; PGEN_.00g127090","Q5ZL74; Q92542","VAMP7_CHICK; NICA_HUMAN","Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1); Nicastrin"
"60","GO:0004518",0.00112099348930703,0.999873749525445,5,33,"nuclease activity","MF","nuclease activity","other molecular function","F","PGEN_.00g061770; PGEN_.00g312690; PGEN_.00g030650; PGEN_.00g277670; PGEN_.00g130160","Q6AZB8; Q6AZB8; Q96MB7; Q8BR93; Q8BR93","HARB1_DANRE; HARB1_DANRE; HARB1_HUMAN; HARB1_MOUSE; HARB1_MOUSE","Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease); Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease); Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease); Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease); Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)"
"61","GO:0001537",0.0023340757661955,0.999880532715235,3,11,"N-acetylgalactosamine 4-O-sulfotransferase activity","MF","N-acetylgalactosamine 4-O-sulfotransferase activity","other molecular function","F","PGEN_.00g049950; PGEN_.00g293980; PGEN_.00g290300","Q8NET6; Q8NCH0; P69478","CHSTD_HUMAN; CHSTE_HUMAN; CHSTB_RAT","Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3); Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1); Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"
"62","GO:0047756",0.017401545054017,0.999082801749497,2,8,"chondroitin 4-sulfotransferase activity","MF","chondroitin 4-sulfotransferase activity","other molecular function","F","PGEN_.00g049950; PGEN_.00g290300","Q8NET6; P69478","CHSTD_HUMAN; CHSTB_RAT","Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3); Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)"
"63","GO:0050694",0.0226836861095372,0.998555070861851,2,10,"galactose 3-O-sulfotransferase activity","MF","galactose 3-O-sulfotransferase activity","other molecular function","F","PGEN_.00g129780; PGEN_.00g237520","P61315; P61315","G3ST3_MOUSE; G3ST3_MOUSE","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3); Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"
"64","GO:1990782",0.0237368871422917,0.998523298938622,2,8,"protein tyrosine kinase binding","MF",NA,NA,NA,"PGEN_.00g325950; PGEN_.00g042660","Q06124; O08586","PTN11_HUMAN; PTEN_MOUSE","Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"65","GO:0070273",0.0331533651268486,0.997409109485669,2,10,"phosphatidylinositol-4-phosphate binding","MF","phosphatidylinositol-4-phosphate binding","other molecular function","F","PGEN_.00g269250; PGEN_.00g329100","Q9JJK2; Q80UK0","LANC2_MOUSE; SESD1_MOUSE","LanC-like protein 2 (Testis-specific adriamycin sensitivity protein); SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein)"
"66","GO:0035255",0.0347475953665875,0.997271065418954,2,9,"ionotropic glutamate receptor binding","MF","ionotropic glutamate receptor binding","signal transduction activity","F","PGEN_.00g199580; PGEN_.00g042660","P46935; O08586","NEDD4_MOUSE; PTEN_MOUSE","E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"67","GO:0043274",0.0382488550066256,0.996768731365042,2,10,"phospholipase binding","MF","phospholipase binding","other molecular function","F","PGEN_.00g211830; PGEN_.00g325950","P16056; Q06124","MET_MOUSE; PTN11_HUMAN","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met); Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)"
"68","GO:0001733",0.0382647748357607,0.996633008662963,2,13,"galactosylceramide sulfotransferase activity","MF","galactosylceramide sulfotransferase activity","other molecular function","F","PGEN_.00g129780; PGEN_.00g237520","P61315; P61315","G3ST3_MOUSE; G3ST3_MOUSE","Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3); Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"
"69","GO:0005484",0.0391341519729642,0.996514051360361,2,13,"SNAP receptor activity","MF","SNAP receptor activity","other molecular function","F","PGEN_.00g185010; PGEN_.00g082970","Q8BVI5; Q5ZL74","STX16_MOUSE; VAMP7_CHICK","Syntaxin-16; Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1)"
"70","GO:0004725",0.0444835996966209,0.985305438338543,6,87,"protein tyrosine phosphatase activity","MF","protein tyrosine phosphatase activity","other molecular function","F","PGEN_.00g325950; PGEN_.00g101900; PGEN_.00g078310; PGEN_.00g345470; PGEN_.00g095430; PGEN_.00g042660","Q06124; P35822; P35992; F1NWE3; Q6XPS3; O08586","PTN11_HUMAN; PTPRK_MOUSE; PTP10_DROME; PTPRS_CHICK; TPTE2_HUMAN; PTEN_MOUSE","Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3); Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48); Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D); Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase); Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)"
"71","GO:0061630",0.0461195319036858,0.98297419758511,7,123,"ubiquitin protein ligase activity","MF",NA,NA,NA,"PGEN_.00g199570; PGEN_.00g224670; PGEN_.00g199580; PGEN_.00g228140; PGEN_.00g268850; PGEN_.00g058240; PGEN_.00g258970","Q9VVI3; Q24307; P46935; O15164; Q5U430; A9JTP3; Q923S6","NEDD4_DROME; DIAP2_DROME; NEDD4_MOUSE; TIF1A_HUMAN; UBR3_MOUSE; BIRC7_XENTR; NEUL1_MOUSE","E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4); Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2); E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4); Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24); E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650); Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7); E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1)"
"72","GO:0004198",0.0476874800512999,0.9953778623716,2,11,"calcium-dependent cysteine-type endopeptidase activity","MF","calcium-dependent cysteine-type endopeptidase activity","other molecular function","F","PGEN_.00g348630; PGEN_.00g014370","O08688; Q11002","CAN5_MOUSE; CANA_DROME","Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3); Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]"
"73","GO:0043027",0.047953206863271,0.991316789540944,3,32,"cysteine-type endopeptidase inhibitor activity involved in apoptotic process","MF","caspase inhibitor activity","enzyme regulator activity","F","PGEN_.00g076180; PGEN_.00g224670; PGEN_.00g058240","Q8JHV9; Q24307; A9JTP3","BIR7A_XENLA; DIAP2_DROME; BIRC7_XENTR","Baculoviral IAP repeat-containing protein 7-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP-A) (Embryonic/Egg IAP) (xEIAP/XLX) (Inhibitor of apoptosis-like protein) (IAP-like protein) (RING-type E3 ubiquitin transferase EIAP-A) (XIAP homolog XLX) (XLX); Death-associated inhibitor of apoptosis 2 (Apoptosis 2 inhibitor) (IAP homolog A) (IAP-like protein) (ILP) (dILP) (Inhibitor of apoptosis 2); Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (E3 ubiquitin-protein ligase EIAP) (Embryonic/Egg IAP) (EIAP/XLX) (RING-type E3 ubiquitin transferase BIRC7)"
>>>>>>> ba1d4294563244071f075ca365e7803e76287964
